Paul Greenall

CEO, FuzeRx and Chief Development Officer, Fuze Health

Fuze Health

Jul 2025 - Current (1 year 1 month)

FuzeRx is the next-generation, digitally-led Pharmacy Services business of Fuze Health, delivering Direct-to-Patient access to therapies, pharmacy care, and specialized pharmacy support to millions of patients and our partners nationwide. We bring specialized expertise in women’s health, complex patient care, and plan benefit management. Combining same-day delivery, clinical support, and benefit guidance. we make treatment simpler, more convenient and effective. As part of Fuze Health’s end-to-end platform—from testing to treatment to overall wellness—FuzeRx connects life sciences companies, providers, health plans, and patients in a single ecosystem. This approach accelerates access to therapies, improving outcomes and driving savings acr

Chief Development Officer

Fuze Health

May 2025 - Jul 2025 (3 months)

Powered by technology and the specialized talents of our people, we are dedicated to transforming patient experiences and enabling more personalized, effective care in a changing healthcare environment. As Chief Development Officer, I lead the design and implementation of our strategy, growth planning, partnerships, acquisitions and investments; as well as operating responsibility for cross-company capabilities and select customer relationships.

Chief Executive Officer

Truepill

Aug 2023 - May 2025 (1 year 10 months)

President

Truepill

Jul 2022 - Aug 2023 (1 year 2 months)

As President, I oversee our global P&L and the development and execution of our business strategy, commercial growth, and operations inclusive of our clinical and distribution teams, our internal business groups, and new ventures/partnerships. Truepill is the leading digital pharmacy experience platform transforming consumer healthcare. We are the power behind well-known consumer health experiences, and are changing the way medications are accessed and the way patients are cared for.

Member Board Of Directors

Unumed

Oct 2021 - Current (4 years 10 months)

Chief Strategy Officer, Senior Partner

Prophet

Jun 2019 - Jun 2022 (3 years 1 month)

Lead the development of the Firm's strategy, P&L, corporate development/M&A, and operations which involves working with Prophet’s leadership team to identify and strengthen the right offerings, capabilities, and talent required to serve our client's most pressing needs. Directly for our clients, leverage my personal experience within healthcare and a large Fortune 10 corporation to counsel executives and Boards working through disruptions to their business, leading effective enterprise transformation, driving innovation, delivering growth strategies, and standing up new businesses and models.

Senior Vice President, Enterprise Strategy & Business Development

McKesson

Jun 2017 - Sep 2018 (1 year 4 months)

Led overall enterprise strategy, growth, portfolio management, mergers / acquisitions, and integrated planning across McKesson's businesses, a $130B revenue global market leader in healthcare services and technology spanning the payer, provider, pharmaceutical, pharmacy, and consumer sectors. • Drove complex strategy formulation and implementation, new product development, business development, innovation, commercial planning, capital allocation, and business transformation that delivered top line and bottom line growth • Led a Board and CEO-sponsored enterprise-wide business Transformation Program tackling all elements of long-term growth, investment strategy, expansion, cost structure, and vision identifying >$1B in long-term value opport

Senior Vice President, Strategy & Business Development

McKesson

Jan 2015 - Jun 2017 (2 years 6 months)

Strategy Leader for McKesson's largest business unit, US Pharmaceutical, a $90B revenue expert in pharmaceuticals, logistics, pharmacy services, and technology. Led a large and diverse team responsible for market analysis and strategy development, planning, and execution to grow the P&L • Central member of business unit executive leadership team • Extensive customer-facing time with large customers in the pharmaceutical, provider, pharmacy, and payer spaces in support of business development and sales pursuits • Drove acquisition and integration of four businesses, contributing >$200M inc. EBIT • Developed strategies for market expansion and growth, delivering >$250M in cumulative EBIT

Vice President, Corporate Strategy & Business Development

McKesson

Mar 2013 - Jan 2015 (1 year 11 months)

Established newly-created team within Corporate Strategy & Business Development organization focused on enterprise-level strategy, portfolio management, innovation, and new growth avenues. • Led complex growth initiatives including foundational strategy work on global expansion that culminated in Executive Committee and Board-level recommendation to acquire European business and initiate Asia business development • Drove all elements of opportunity identification, business case development, due diligence, executive approvals for European deal; spent 12 months in Germany/EU leading acquisition integration • Oversaw overhaul of strategic planning processes and annual board planning meetings to facilitate increased rigor • Researched, prepared

Senior Director, Corporate Strategy & Business Development

McKesson

Mar 2011 - Mar 2013 (2 years 1 month)

Led complex strategic projects from data analysis and ideation stages through to execution and implementation. • Developed cross-McKesson strategy for provider solutions; collaborated with leaders from across BUs to translate strategy into build/partner/buy decisions and go-to-market opportunities; led customer development activities • Liaised with Public Affairs, Law Department, and Executive leaders to assess Government impact to our businesses

Director, Finance

McKesson

Oct 2008 - Feb 2011 (2 years 5 months)

Responsible for the direction and oversight of strategic, operational, and financial assessments in the areas of project management, customer-facing software development, operations optimization, regulatory compliance, vendor management • Led a team of nineteen professionals; proven track record in staff development and promotion; managed $10M budget

Senior Manager, Advisory Services

ey

Sep 2002 - Aug 2009 (7 years)

Management consulting services focused on the healthcare, pharmaceutical, and large complex multinational organizations in both the private and public sectors. Client base included large health systems, health plans, academic medical centers, pharmaceutical companies, provider groups, healthcare services organizations, and pharmacies. • Responsible for the direction, coordination and execution of advisory engagements within large complex clients in the areas of strategy, technology, portfolio, system implementation and program management • Oversaw business development and relationship management for $14.5 million/year fee-based book of business • Led teams supporting two large merger and acquisition programs for two Fortune 20 corpor

Product Marketing Associate

Mars

May 2000 - Sep 2001 (1 year 5 months)

Liaised with global advertising agency partners in the creation and execution of marketing segmentation analysis, collateral, and new brand strategy for the Flavia ® beverage brand system.

Business Systems Trainer

WHSmith

Aug 1998 - May 2000 (1 year 10 months)

About

Detail

Timeline

Résumé